A Study to Evaluate the Onset of Effect and Time Course of Change in Lung Function With Benralizumab in Severe, Uncontrolled Asthma Patients With Eosinophilic Inflammation
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Reynold A Panettieri, Doctor of Medicine
Child Health Institute of NJ, 89 French Street, Suite 4210, New Brunswick, NJ, 08901, USA
Principal InvestigatorKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
54 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Curicó, Chile
- Research Site
Santiago, Chile
- Research Site
Santiago, Chile
- Research Site
Santiago, Chile
- Research Site
Bamberg, Germany
- Research Site
Darmstadt, Germany
- Research Site
Frankfurt, Germany
- Research Site
Frankfurt am Main, Germany
- Research Site
Frankfurt am Main, Germany
- Research Site
Hamburg, Germany
- Research Site
Hamburg, Germany
- Research Site
Hanover, Germany
- Research Site
Hanover, Germany
- Research Site
Hanover, Germany
- Research Site
Mainz, Germany
- Research Site
München, Germany
- Research Site
Balassagyarmat, Hungary
- Research Site
Edelény, Hungary
- Research Site
Farkasgyepü, Hungary
- Research Site
Gödöllő, Hungary
- Research Site
Hajdúnánás, Hungary
- Research Site
Komárom, Hungary
- Research Site
Miskolc, Hungary
- Research Site
Pécs, Hungary
- Research Site
Pécs, Hungary
- Research Site
Iloilo City, Philippines
- Research Site
Lipa City, Philippines
- Research Site
Manila, Philippines
- Research Site
Quezon City, Philippines
- Research Site
Cheongju-si, South Korea
- Research Site
Daegu, South Korea
- Research Site
Jeonju, South Korea
- Research Site
Seoul, South Korea
- Research Site
Seoul, South Korea
- Research Site
Seoul, South Korea
- Research Site
Seoul, South Korea
- Research Site
Seoul, South Korea
- Research Site
Seoul, South Korea
- Research Site
Scottsboro, Alabama, United States
- Research Site
Gilbert, Arizona, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Nov 2016
- Primary completion
- 1 Aug 2018
- Completion
- 1 Aug 2018
- Last update posted
- 29 Oct 2019
- Registered enrollment
- 233
- Registry id
- NCT02869438
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.